Literature DB >> 2306219

Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components.

F Gavilanes1, J Gomez-Gutierrez, M Aracil, J M Gonzalez-Ros, J A Ferragut, E Guerrero, D L Peterson.   

Abstract

Most of the lipid components of hepatitis B surface antigen (HBsAg) can be removed by treatment with the non-ionic non-denaturing detergent beta-D-octyl glucoside (OG) followed by centrifugation through caesium chloride linear density gradients (density 1.15-1.32 g/ml). The conformational changes induced by the elimination of lipids decreased the helical content of HBsAg proteins from 52 to 28% as indicated by c.d. techniques. Measurements of the extent of quenching of protein fluorescence by iodide showed that half of the tryptophan residues which are buried in the native structure of HBsAg particles are brought close to the surface of the molecule by such conformational changes. The antigenic activity, as measured by binding to polyclonal antibodies, was decreased upon removal of lipids. Moreover, the six different antigenic sites recognized by our panel of monoclonal antibodies decreased their capacity to bind to the corresponding antibody when lipids were removed. However, the extent of this decrease differed for the different antibodies. Thus the apparent dependence of antibody binding on the lipid content seemed to indicate a greater involvement of the lipid-protein interaction for some of the epitopes than for others.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306219      PMCID: PMC1133710          DOI: 10.1042/bj2650857

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Structural characterization of recombinant hepatitis B surface antigen protein by mass spectrometry.

Authors:  M E Hemling; S A Carr; C Capiau; J Petre
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

4.  A BASIC microcomputer program to calculate the secondary structure of proteins from their circular dichroism spectrum.

Authors:  L Menéndez-Arias; J Gómez-Gutiérrez; M García-Ferrández; A García-Tejedor; F Morán
Journal:  Comput Appl Biosci       Date:  1988-11

5.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

6.  Stability of the lipid and protein of hepatitis-associated (Australia) antigen.

Authors:  C Y Kim; D M Bissell
Journal:  J Infect Dis       Date:  1971-05       Impact factor: 5.226

7.  Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test.

Authors:  G N Vyas; E W Williams; G G Klaus; H E Bond
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

8.  Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion.

Authors:  S S Lehrer
Journal:  Biochemistry       Date:  1971-08-17       Impact factor: 3.162

9.  Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies.

Authors:  D L Peterson; D A Paul; J Lam; I I Tribby; D T Achord
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

10.  Expression of hepatitis B virus surface antigen in yeast.

Authors:  R A Hitzeman; C Y Chen; F E Hagie; E J Patzer; C C Liu; D A Estell; J V Miller; A Yaffe; D G Kleid; A D Levinson; H Oppermann
Journal:  Nucleic Acids Res       Date:  1983-05-11       Impact factor: 16.971

View more
  6 in total

1.  Biochemical and biophysical characterization of maize-derived HBsAg for the development of an oral vaccine.

Authors:  Shweta Shah; Celine A Hayden; Maria E Fischer; A Gururaj Rao; John A Howard
Journal:  Arch Biochem Biophys       Date:  2015-10-28       Impact factor: 4.013

2.  Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Authors:  Isabelle Desombere; Annick Willems; Yvonne Gijbels; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.

Authors:  Anke M Mulder; Bridget Carragher; Victoria Towne; Yuan Meng; Yang Wang; Lance Dieter; Clinton S Potter; Michael W Washabaugh; Robert D Sitrin; Qinjian Zhao
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

Review 4.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

5.  Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles.

Authors:  Haitao Liu; Xupeng Hong; Ji Xi; Stephan Menne; Jianming Hu; Joseph Che-Yen Wang
Journal:  Sci Adv       Date:  2022-08-05       Impact factor: 14.957

Review 6.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.